FDA Inspection 1130955 — Synapse Biomedical Inc
The FDA completed an inspection of Synapse Biomedical Inc on Oct 7, 2020 in Oberlin, OH. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Devices.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 7, 2020
- Fiscal Year
- 2021
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Oberlin, OH (United States)